Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-14 · accession 0000875320-25-000085 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-19 | 2025-02-18 | VRTX | Biller Jonathan | EVP, CLO | S - Sale | $455.06 | -1,657 | 17.6K | -9% | -$754.0K | |
| 2025-02-19 | 2025-02-14 | VRTX | Biller Jonathan | EVP, CLO | F - Tax | $463.46 | -1,504 | 19.3K | -7% | -$697.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-18 | S | D | 1,657 | $455.06 | 17,606 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-14 | F | D | 1,504 | $463.46 | 19,263 | D | — | — |